| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 130279 | 7H-1,2,3-Triazolo[4,5-d]pyrimidin-7-one, 3,4-dihydro-3-.beta.-D-ribofuranosyl- (9CI) | 0.00352002370824895 | 0.28763043 |
| NSC 132791 | Butyric acid, 2-hydroxy-2-methyl-, 4-ester with 1,3a.beta.,4,7,7a.alpha.,11,11a,11b.alpha.-octahydro-1.alpha.,2.alpha.,4.beta.,11.beta.-tetrahydroxy-3.alpha.,8,11a.beta.-trimethyl-2H-1,11c.beta.-(epo | 0.00352002370824895 | -0.28745259 |
| NSC 133118 | 2H-1,2,3-Triazolo[4,5-d]pyrimidin-7-amine, 2-.beta.-D-ribofuranosyl- (9CI) | 0.00352002370824895 | 0.097375866 |
| NSC 144163 | Quinoxaline, 6-chloro-2,3-bis(iodomethyl)- | 0.00352002370824895 | 0.025775627 |
| NSC 349622 | Cytovaricin | 0.00407837248037199 | -0.030187886 |
| NSC 643836 | Null | 0.00407837248037205 | 0.018003127 |
| NSC 671765 | 3-[2-pyrrolidino] ethoxy-17-butyl-17-aza-1,3,5(10)-estratriene-16,17.alpha.-dione | 0.00407837248037205 | -0.085854922 |
| NSC 684043 | 1H-Imidazole-4-carboxamide, 5-[[(2-amino-2-carboxyethyl)thio]azo]- | 0.00407837248037205 | 0.22066625 |
| NSC 684144 | Null | 0.00407837248037205 | -0.04586207 |
| NSC 697286 | LY 294002 | 0.00407837248037205 | -0.053824051 |